logo

For the Inventor, By the Inventor

Kennett Square, PA, United States of America

James C Kauer

This inventor holds 20 USPTO granted patents, plus 1 CIPO patent, primarily in Neurological Disorders. Top assignees: Cephalon, Inc., E.i. Dupont De Nemours and Company, Kyowa Hakko Kogyo Co., Ltd.. Active years: 1976-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James C Kauer. Retrieved from https://idiyas.com/inventor/james-c-kauer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20

% Patents Active = 100.0


Average Co-Inventor Count = 2.7

ph-index = 12

Forward Citations = 380(Granted Patents)


Location History:

  • Kennet Square, PA (US) (1997 - 1998)
  • Kennett Sq., PA (US) (1998)
  • Kennett Square, PA (US) (1976 - 2004)

Company Filing History:

goldMedal14 out of 248 
 
Cephalon, Inc.
 patents
silverMedal5 out of 16,339 
 
E.i. Dupont De Nemours and Company
 patents
bronzeMedal4 out of 730 
 
Kyowa Hakko Kogyo Co., Ltd.
 patents
4. 1 out of 9 
 
Kyowa Hakko Kogyo
 patents
5. 1 out of 16,048 
 
University of California
 patents
where one patent can have more than one assignee

Years Active: 1976-2004

Loading Chart...
Loading Chart...
Areas of Expertise:
Insulin-Like Growth Factors
Protease Inhibitors
Protein Kinase Inhibitors
Neurological Disorders
Nerve Growth Factor
Photoreactive Peptides
K-252a Derivatives
Crown Ethers
Aroylcrownethers
Acylcrownether Oximes
Benzoylphenylalanines
Aralkylcarbamoyl Peptide Alcohols
20 patents (USPTO):Explore Patents
1. 6693076 - Treating disorders by application of insulin-like growth factors and analogs (2004-02-17),
2. 5990083 - Multicatalytic protease inhibitors (1999-11-23),
3. 5830870 - Multicatalytic protease inhibitors (1998-11-03),
4. 5776897 - Treating disorders by application of insulin-like growth factors and (1998-07-07),
5. 5756494 - Protein kinase inhibitors for treatment of neurological disorders (1998-05-26),
6. 5741808 - Protein kinase inhibitors for treatmen of neurological disorders (1998-04-21),
7. 5703045 - Treating disorders by application of insulin-like growth factors and (1997-12-30),
8. 5652214 - Treating disorders by application of insulin-like growth factors and (1997-07-29),
9. 5621101 - Protein kinase inhibitors for treatment of neurological disorders (1997-04-15),
10. 5621100 - K-252a derivatives for treatment of neurological disorders (1997-04-15),
11. 5614649 - Multicatalytic protease inhibitors (1997-03-25),
12. 5550262 - Multicatalytic protease inhibitors (1996-08-27),
13. 5461146 - Selected protein kinase inhibitors for the treatment of neurological (1995-10-24),
14. 5134121 - Nerve growth factor peptides (1992-07-28),
15. 5093317 - Treating disorders by application of insulin-like growth factor (1992-03-03),

Title: The Innovative Journey of James C Kauer

Introduction: James C Kauer, a distinguished inventor hailing from Kennett Square, PA (US), has made significant contributions to the field of technology through his groundbreaking inventions.

Latest Patents: James C Kauer's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a cutting-edge medical device designed to improve patient outcomes in critical care settings.

Career Highlights: With a career spanning over two decades, James C Kauer has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized with multiple awards and accolades in the industry.

Collaborations: Throughout his career, James C Kauer has collaborated with leading technology companies, research institutions, and universities to bring his inventions to life. His ability to work across disciplines and leverage the expertise of others has been instrumental in the success of his projects.

Conclusion: James C Kauer's passion for innovation and commitment to pushing the boundaries of technology continue to inspire the next generation of inventors. His impact on the industry is undeniable, and his legacy will undoubtedly endure for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…